Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Quest's C. difficile Molecular Test

NEW YORK (GenomeWeb News) – Quest Diagnostics said today that the US Food and Drug Administration has given 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

The test is from Quest's wholly owned business Focus Diagnostics and is for aiding in the diagnosis of C. difficile. Simplexa tests use real-time PCR to qualitatively detect viruses, bacteria, and other analytes, and the C. difficile test uses a proprietary chemistry to eliminate nucleic acid sample extraction, allowing hospitals and other laboratories to achieve test results in about one hour, Quest said.

The test is performed on liquid or unformed human stool samples to detect the toxin B (tcdB) gene of C. difficile, including NAP1. Focus launched the test in Europe during the second quarter of 2011.

In the US about 14,000 people die each year from C. difficile-associated diseases, Quest said, citing statistics from the US Centers for Disease Control and Prevention.

"Fast, reliable PCR tests that are highly specific and sensitive in the detection of the tcdB gene … are essential for identifying and treating this infection as well as containing its spread," Jay Lieberman, medical director of infectious disease for Quest and Focus, said in a statement.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.